MedPath

Performance of low risk criteria in the evaluation of direct oral challenge for children with beta-lactam allergy (multicenter study)

Phase 4
Recruiting
Conditions
the patients with low-risk betalactam allergy
betalactam allergy
Registration Number
TCTR20210225004
Lead Sponsor
Ramathibodi hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
400
Inclusion Criteria

children aged 5-18 years old with history of low-risk betalactam allergy

Exclusion Criteria

high-risk of betalactam allergy
immunocompromised
uncontrolled cardiac/pulmonary disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
no reaction after drug challenge after continue drug challenge for 5 days negative test
Secondary Outcome Measures
NameTimeMethod
protocol publication for non-allergist within 1 yr of the end of study accuracy of protocol
© Copyright 2025. All Rights Reserved by MedPath